These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 600713)

  • 1. [Hyperammonemia and hepatic encephalopathy in cirrhotics receiving spironolactone (author's transl)].
    Imler M; Schlienger JL
    Nouv Presse Med; 1977 Nov; 6(37):3407-10. PubMed ID: 600713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why and when to measure ammonemia in cirrhosis?
    Mallet M; Weiss N; Thabut D; Rudler M
    Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):505-511. PubMed ID: 29551609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complications of diuretic therapy in patients with cirrhosis.
    Sherlock S; Walker JG; Senewiratne B; Scott A
    Ann N Y Acad Sci; 1966 Nov; 139(2):497-505. PubMed ID: 5230290
    [No Abstract]   [Full Text] [Related]  

  • 4. Ammonia metabolism in the gut.
    Summerskill WH; Wolpert E
    Am J Clin Nutr; 1970 May; 23(5):633-9. PubMed ID: 5444997
    [No Abstract]   [Full Text] [Related]  

  • 5. [Present-day therapy of hepatic encephalopathy (author's transl)].
    Imler M
    MMW Munch Med Wochenschr; 1976 Dec; 118(52-53):1685-94. PubMed ID: 827698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients].
    Wang LJ; Cai JT; Chen T; Lü B; Si JM
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):654-7. PubMed ID: 17074151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood ammonia levels and hepatic encephalopathy induced by CCl4 in rats.
    Yamamoto H; Sugihara N
    Toxicol Appl Pharmacol; 1987 Dec; 91(3):461-8. PubMed ID: 2962338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medium chain triglycerides and hepatic encephalopathy.
    Morgan MH; Bolton CH; Morris JS; Read AE
    Gut; 1974 Mar; 15(3):180-4. PubMed ID: 4841275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine-induced hepatic coma in dogs.
    Merino GE; Jetzer T; Doizaki WM; Najarian JS
    Am J Surg; 1975 Jul; 130(1):41-46. PubMed ID: 1155716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urea and spironolactone therapy].
    Schwarzbach W; Bunzl W
    Munch Med Wochenschr; 1973 Jan; 115(3):76-80. PubMed ID: 4739290
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].
    Yang CS; Cao SY; He XJ; Wang YX; Zhang YL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut ammonia production and its modulation.
    Romero-Gómez M; Jover M; Galán JJ; Ruiz A
    Metab Brain Dis; 2009 Mar; 24(1):147-57. PubMed ID: 19067141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of diuretic therapy in hepatic cirrhosis.
    Sherlock S; Senewiratne B; Scott A; Walker JG
    Lancet; 1966 May; 1(7446):1049-52. PubMed ID: 4160838
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 15. Venous, arterial, and arterialized-venous blood ammonia levels and their relationship to hepatic encephalopathy after propranolol.
    Snady H; Lieber CS
    Am J Gastroenterol; 1988 Mar; 83(3):249-55. PubMed ID: 3344727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of chronic uremia on portal and systemic ammonemia in normal and portal-strictured rats.
    Imler M; Schlienger JL
    J Lab Clin Med; 1979 Dec; 94(6):872-8. PubMed ID: 501211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ammonia and inflammation in minimal hepatic encephalopathy.
    Shawcross DL; Wright G; Olde Damink SW; Jalan R
    Metab Brain Dis; 2007 Mar; 22(1):125-38. PubMed ID: 17260161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy.
    Nicolao F; Efrati C; Masini A; Merli M; Attili AF; Riggio O
    J Hepatol; 2003 Apr; 38(4):441-6. PubMed ID: 12663235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats.
    Hsu SJ; Wang SS; Huo TI; Lee FY; Huang HC; Chang CC; Hsin IF; Ho HL; Lin HC; Lee SD
    J Pharmacol Exp Ther; 2015 Oct; 355(1):117-24. PubMed ID: 26260462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.